Molecular Partners Stock Target Price and Analyst Consensus
| MOLN Stock | USD 4.33 0.06 1.37% |
The current analyst and expert consensus on Molecular Partners is Strong Buy, with 2 strong buy opinions. The current projected Molecular Partners target price consensus is 10.26 with 3 analyst opinions. Check out Macroaxis Advice on Molecular Partners to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Molecular Partners analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Molecular Partners executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Molecular Partners. We encourage you to use your own analysis of Molecular Partners to validate this buy or sell advice. Molecular Partners buy-or-sell recommendation module provides average expert sentiment on the projected Molecular Partners target price to derive its highest and lowest estimates based on projected price volatility of 3.5011.
Lowest Forecast 9.34 | Highest Forecast 11.39 | Target Price 10.26 |
Molecular |
It's important to approach Molecular Partners' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Molecular Partners Target Price Consensus
Molecular target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Molecular Partners' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Molecular analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Molecular stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Molecular Partners, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMolecular Partners Target Price Projection
Molecular Partners' current and average target prices are 4.33 and 10.26, respectively. The current price of Molecular Partners is the price at which Molecular Partners AG is currently trading. On the other hand, Molecular Partners' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Molecular Partners Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Molecular Partners Target Price
Molecular Partners Analyst Ratings
Molecular Partners' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Molecular Partners stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Molecular Partners' financials, market performance, and future outlook by experienced professionals. Molecular Partners' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Molecular Partners price targets
Molecular Partners' stock target price is an estimate of its future price, usually made by analysts. Using Molecular Partners' target price to determine if it is a suitable investment can be done through the following steps:- Look at Molecular Partners' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Molecular Partners' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Molecular Partners Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Molecular Partners is a key component of Molecular Partners valuation and have some predictive power on the future returns of a Molecular Partners.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested few shares | |
 | ESG Investing Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Molecular Partners to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.